Cargando…
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
IMPORTANCE: Additional lipid-lowering therapy options are needed for patients who cannot achieve sufficient decreases in low-density lipoprotein cholesterol (LDL-C) levels using statins alone or for those who are statin intolerant. OBJECTIVE: To conduct a pooled analysis of phase 3 randomized clinic...
Autores principales: | Banach, Maciej, Duell, P. Barton, Gotto, Antonio M., Laufs, Ulrich, Leiter, Lawrence A., Mancini, G. B. John, Ray, Kausik K., Flaim, JoAnn, Ye, Zhan, Catapano, Alberico L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330832/ https://www.ncbi.nlm.nih.gov/pubmed/32609313 http://dx.doi.org/10.1001/jamacardio.2020.2314 |
Ejemplares similares
-
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
por: Leiter, Lawrence A., et al.
Publicado: (2022) -
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019) -
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019) -
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022) -
Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)